Zacks upgrades Smith & Nephew to 'buy' rating: 5 points

Spinal Tech

Zacks Investment Research upgraded Smith & Nephew from a "hold" rating to a "buy" rating, according to Washington News Wire.

Here are five points:

 

1. Zacks currently has a $38 price target on the stock.

 

2. Smith & Nephew has a consensus rating of "hold" and a consensus target price of $39.25 from all the brokerages covering the firm.

 

3. The company's stock has a 50-day moving average of $32.91 and a 200-day moving average of $33.54.

 

4. Smith & Nephew has a one-year low of $30.23 and a one-year high of $37.84.

 

5. The stock has a market cap of $15.2 billion.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers